Abstract Introduction/Aims In this study we investigated COVID‐19 vaccination–related
adverse events (ADEs) 7 days postvaccination in patients with idiopathic inflammatory …

Vaccine hesitancy is considered a major barrier to achieving herd immunity against COVID-
19. While multiple alternative and synergistic approaches including heterologous …

The SARS-CoV-2 pandemic raised many challenges for all patients with chronic conditions
and those with autoimmune diseases, both adults and children. Special attention is paid to …

Objectives COVID-19 vaccines have been proven to be safe in the healthy population.
However, gaps remain in the evidence of their safety in patients with systemic autoimmune …

Objectives The COVID-19 vaccination in autoimmune diseases (COVAD) study aimed to
assess short-term COVID-19 vaccination-related adverse events (AEs) in RA patients …

This study defines key issues for sustainable healthcare policy in COVID-19 period. For this
purpose, 9 different criteria that affect vaccine hesitancy are selected with the help of a …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination plays a crucial
role as pivotal strategy to curb the coronavirus disease-19 (COVID-19) pandemic. The …

Diabetes mellitus is one of the most common comorbid conditions encountered in patients
with severe acute respiratory syndrome coronavirus 2 infection accompanied by significantly …

Objectives We aimed to compare the spectrum and severity of COVID-19 and vaccine
breakthrough infections (BIs) among patients with IIMs, other systemic autoimmune and …

Objective Flares of autoimmune rheumatic diseases (AIRDs) following COVID-19
vaccination are a particular concern in vaccine-hesitant individuals. Therefore, we …